Compass Group
CMPGY | OTC
$30.24
+$0.23 (+0.77%)
At close: Sep 22, 2026, 3:59 PM ET
$30.20
-$0.04 (-0.13%)
After-hours:
Sep 22, 2026, 4:00 PM ET
Company Profile
No company profile available.
Key Executives
No executive data available
Contact Details
n/a
n/a
Stock Details
| Ticker Symbol | CMPGY |
| Exchange | n/a |
| Fiscal Year | n/a |
| Reporting Currency | n/a |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| SIC Code | n/a |
Recent News
- 1 day ago / marketbeat.comCompass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
- 1 day ago / marketbeat.comCompass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances
- 1 day ago / benzinga.comCompass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug
- 2 days ago / globenewswire.comCompass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback
- 2 days ago / marketbeat.comCompass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears
- 8 days ago / businesswire.comCompass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
- 9 days ago / businesswire.comCompass Pathways Launches ‘Change the Tune in TRD' in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
- 10 days ago / 247wallst.comCoinbase Jumps 6% on Compass Point Upgrade Ahead of Senate CLARITY Act Vote; Strategy Climbs 3%, MARA Slips
- 10 days ago / businesswire.comNinth Wave's AI-Powered Compass with Amazon Bedrock Cuts API Integration Time Up to 95%
- 11 months ago / businesswire.comCompass Pathways to Announce Third Quarter Financial Results on November 4, 2025
Add to Watchlist
Select watchlists to add or remove CMPGY